You are here
LNKCHEMSOLUTIONS
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics
Amount: $296,413.00DESCRIPTION: The goal of the proposed project is to develop a biocompatible ultrafine particle-based vector system for the intranasal delivery of clozapine for the pharmacological therapy of treatment ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health -
Nanoparticles and Nanocapsules for Glioma Targeting
Amount: $2,000,001.00DESCRIPTION (provided by applicant): Malignant gliomas represent a heterogeneous family of tumors that are poorly responsive to current treatments. A major obstacle to the effective management of thes ...
SBIRPhase II2011Department of Health and Human Services National Institutes of Health -
Improved Formulations to Enhance Bio-availability for Antisense Therapeutics
Amount: $70,000.00In general, many biological and chemical agents affect the lungs directly or indirectly, even if the respiratory system is not the primary target organ of a military or terrorist attack. Both in the c ...
SBIRPhase I2010Department of Defense Office for Chemical and Biological Defense -
Development of New Hemostatic Dressings
Amount: $399,994.00DESCRIPTION (provided by applicant): A multidisciplinary team of researchers seeks to develop novel and economically feasible implantable hemostatic dressings for severe (e.g. arterial) bleeding. Key ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Nanoparticles and Nanocapsules for Glioma Targeting
Amount: $400,001.00DESCRIPTION (provided by applicant): LNK Chemsolutions LLC collaborates with researchers from the University of Chicago to develop nanocapsule technology for enhanced delivery to gliomas. Preliminary ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Nanoengineered Encapsulation of Enzyme Chiral Catalysts and Other Proteins in Their Native State
Amount: $750,000.00The commercial opportunities for products based on delicate biomolecules, such as enzymes and therapeutic proteins, are growing at a strong pace. However, many proteins of great commercial value, inc ...
SBIRPhase II2006Department of Energy -
SBIR Phase I: Catalytic Traps for Capture of Gas-Phase Toxic Linear Molecules
Amount: $100,000.00This Small Business Innovation Research (SBIR) Phase I project will explore the use of a material comprising a fibrous substrate and an inorganic adsorbent/catalytic coating for removal of toxic small ...
SBIRPhase I2006National Science Foundation -
STTR Phase I: Nanoengineered Encapsulation of Therapeutics
Amount: $100,000.00This Small Business Technology Transfer (STTR) Phase I project is a feasibility study for the design of true core-shell type nonocapsules for drug delivery. The research will focus on strategies aime ...
STTRPhase I2006National Science Foundation -
Micro/Nano-Encapsulation of Partial Oxidation Biocatalysts
Amount: $99,999.0078011S Many industrial liquid-phase catalytic processes that require the use of some kind of active species (e.g. sensors, biosensors, chelating agents, and chemical traps) cannot be ¿heterogeneized ...
SBIRPhase I2005Department of Energy -
Submicron Particles and Fibers for Toxicological Studies
Amount: $376,119.00DESCRIPTION (provided by applicant): This Phase I SBIR program is aimed at initiating a business venture dedicated to the manufacturing of nanoparticulates for toxicology research. The rate of nanotec ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health
